{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
MDxHealth SA Hits New 52-Week High of USD 4.74, Up 298%
MDxHealth SA achieved a new 52-week high of USD 4.74 on September 23, 2025, marking a 298.23% increase over the past year. With a market capitalization of USD 176 million, the company has a notable return on equity of 3,461.10%, despite not offering dividends and facing a complex valuation.
MDxHealth SA Hits New 52-Week High of $4.68, Up 314%
MDxHealth SA achieved a new 52-week high of USD 4.68 on September 22, 2025, reflecting a 314.16% increase over the past year. Despite being a loss-making microcap in the Pharmaceuticals & Biotechnology sector, the company boasts a market capitalization of USD 176 million and notable financial metrics.
MDxHealth SA Hits New 52-Week High of USD 4.17, Up 266% Year-Over-Year
MDxHealth SA achieved a new 52-week high of USD 4.17 on September 19, 2025, reflecting a substantial increase over the past year. The company, with a market capitalization of USD 176 million, has shown impressive financial metrics despite being currently loss-making, highlighting its volatility and growth potential in the pharmaceuticals sector.
Is MDxHealth SA technically bullish or bearish?
As of September 11, 2025, MDxHealth SA shows a bullish technical trend with strong weekly indicators, despite mixed monthly signals, and has significantly outperformed the S&P 500 year-to-date with a return of 64.56%.
MDxHealth SA Hits New 52-Week High of USD 3.93, Up 245%
MDxHealth SA achieved a new 52-week high of USD 3.93 on September 18, 2025, reflecting a 245.13% increase over the past year. The company, with a market capitalization of USD 176 million, demonstrates strong operational efficiency despite being loss-making and lacking a dividend.
Is MDxHealth SA technically bullish or bearish?
As of April 21, 2025, the trend is mildly bearish with mixed signals, including a bullish MACD weekly but bearish RSI and moving averages, indicating caution is advised.
Who are in the management team of MDxHealth SA?
As of March 2022, the management team of MDxHealth SA includes Non-Executive Independent Chairman Mr. Mark Shaffar, CEO and Director Mr. Michael McGarrity, and Non-Executive Directors Mr. Rudi Marien, Mr. Jan Pensaert, Mme. Ruth Devenyns, and Mr. Walter Narajowski. They oversee the company's strategic direction and governance.
What does MDxHealth SA do?
MDxHealth SA is a Belgium-based healthcare company specializing in molecular diagnostics for cancer treatment, with recent net sales of $24 million and a market cap of $97.51 million. The company reported a net profit of -$9 million as of March 2025.
How big is MDxHealth SA?
As of Jun 18, MDxHealth SA has a market capitalization of 97.51 million, with net sales of 94.51 million and a net profit of -38.77 million over the latest four quarters. Shareholder's funds are 14.84 million, and total assets are 157.33 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
